Advances in oncolytic virotherapy
Stephen J. Russell, John C. Bell, Christine E. Engeland, Grant McFadden
Abstract
Recent years have seen rapid advances in the preclinical development and clinical evaluation of oncolytic (cancer-lysing) virus-based therapies, and these are emerging as treatment modality for some cancers. There are challenges to address, however, if we are to maximize the impact of these therapies in patients.
Topics & Concepts
Oncolytic virusVirotherapyMedicineCancerViral therapyVirusVirologyCoronavirus disease 2019 (COVID-19)Internal medicineDiseaseInfectious disease (medical specialty)Virus-based gene therapy researchBacteriophages and microbial interactionsCancer Research and Treatments